Channel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!About CHRO
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil.
CEOScott M. Plesha
CEOScott M. Plesha
Employees—
Employees—
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded
Founded
Employees—
Employees—
CHRO Key Statistics
Market cap7.85M
Market cap7.85M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume349.61K
Average volume349.61K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$54.29
52 Week high$54.29
52 Week low$4.50
52 Week low$4.50
People also own
Based on the portfolios of people who own CHRO. This list is generated using Robinhood data, and it’s not a recommendation.